Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.
Press releases published on May 14, 2025

MotusAcademy and European Rehabilitation Robotics School Sign Landmark MOU to Advance Global Rehabilitation Education
The partnership launches monthly webinars, hands-on workshops, and open-access resources (2025–2030) to democratise rehabilitation robotics education worldwide. ROME, ITALY, May 13, 2025 /EINPresswire.com/ -- MotusAcademy and the European Rehabilitation …

Arcturis and University College London Hospitals Enter Strategic Partnership
Multi-year agreement to focus on generation of regulatory grade real-world datasets to advance development and adoption of new medicines OXFORD, UNITED KINGDOM, May 14, 2025 /EINPresswire.com/ -- Arcturis, the UK leader in the curation of deep, multi- …

United Way of Hunterdon County Offers Free Youth Mental Health Training to Address Escalating Youth Mental Health Crisis
Learn how to support teens in crisis—free Youth Mental Health First Aid training for parents, coaches, and volunteers who care about youth well-being. FLEMINGTON, NJ, UNITED STATES, May 13, 2025 /EINPresswire.com/ -- United Way of Hunterdon County is …

Sevaro Launches Nationwide Stroke Awareness Campaign With Racecars, Storybooks, and Student Heroes
CHARLOTTE, N.C., May 14, 2025 (GLOBE NEWSWIRE) -- A stroke happens every 40 seconds in the U.S.—and every minute without treatment can cost a person 1.9 million brain cells. This May, during Stroke Awareness Month Sevaro Health is shifting the narrative— …

The Best Steroids for Cutting, Muscle Growth & Strength for Weight Training - Top Legal Steroid Stacks for Bulking, Fat Loss, Getting Shredded & Ripped - CrazyBulk
New York City, NY, May 14, 2025 (GLOBE NEWSWIRE) -- For serious bodybuilders and weightlifters, achieving fast muscle growth and that shredded look takes more than just hard work in the gym. The right steroid stack will push past limits, pack on lean …

“Say the ‘S’ word:” Physician-Patient Alliance for Health & Safety Launches CME Sepsis Courses
Chicago, IL, May 14, 2025 (GLOBE NEWSWIRE) -- “Say the ‘S’ word:” Physician-Patient Alliance for Health …

Kura Oncology and Kyowa Kirin Announce Combination Data for Ziftomenib in Oral Presentation at the 2025 European Hematology Association (EHA) Congress
– Ziftomenib combined with 7+3 in 1L NPM1-m or KMT2A-r AML patients selected for oral presentation on Thursday, June 12th – – Updated dataset to be presented in oral presentation at EHA2025 Congress – SAN DIEGO and TOKYO, May 14, 2025 (GLOBE NEWSWIRE) -- …

Agios to Highlight Pyruvate Kinase Activation Portfolio with New Data in Rare Blood Disorders at 30th EHA Congress
CAMBRIDGE, Mass., May 14, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today announced that new data on the company’s PK …

Nurix Therapeutics Announces Presentations of Clinical Data at the 30th European Hematology Association Congress and the 18th International Conference on Malignant Lymphoma
SAN FRANCISCO, May 14, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, today announced that …

Co-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference
Salt Lake City, Utah, May 14, 2025 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that …

Syndax Announces Data Presentations at EHA 2025 Showcasing Revuforj® (revumenib) and Niktimvo™ (axatilimab-csfr)
– Revumenib abstracts highlight compelling results in acute leukemia across the frontline and R/R setting and multiple genetic populations, including mNPM1, KMT2Ar, and NUP98r – – Axatilimab abstracts highlight the robust responses observed in different …

Terns Pharmaceuticals Selected for Oral Presentation at European Hematology Association Congress For Preclinical Data on Novel Allosteric BCR-ABL Inhibitor TERN-701
Preclinical data highlight improved potency vs. asciminib across multiple clinically relevant variants of BCR-ABL including difficult-to-treat resistance mutations Early dose-escalation data from Phase 1 CARDINAL study of TERN-701 in CML patients showed …

Autonomix CEO Brad Hauser to Present at Virtual Investor’s Closing Bell Event
Live webcast followed by an interactive Q…

Vivos Therapeutics Schedules Release of First Quarter 2025 Financial Results and Conference Call
LITTLETON, Colo., May 14, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary …

Progyny Appoints Two Renowned Women’s Health Experts to Medical Advisory Board
NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced the appointment of Morehouse School of Medicine’s Regional Dean for Seattle and Puget Sound’s Dr. …

Outset Medical Appoints Industry Veteran Kevin O’Boyle to its Board of Directors
SAN JOSE, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced the appointment of …

Epilepsy Foundation of America to Present Lifetime Accelerator Award to Orrin Devinsky, M.D.
BOWIE, Md., May 14, 2025 (GLOBE NEWSWIRE) -- Internationally acclaimed neurologist and epilepsy researcher Dr. Orrin Devinsky will be honored with the Lifetime Accelerator Award during the Epilepsy Therapies …

Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month
New national awareness day will foster greater understanding of transcranial magnetic stimulation (TMS) treatment The company will celebrate on social media, sharing patient and provider stories that highlight the impact NeuroStar has as a safe, effective, …

Ernexa Therapeutics Establishes Texas Subsidiary to Support Continued Development of ERNA-101 and Future Clinical Operations
CAMBRIDGE, Mass., May 14, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today announced the formation of ErnexaTX2, a wholly owned subsidiary …

UPDATE -- Abeona Therapeutics® and Lurie Children's Open First Center for ZEVASKYN™ Gene Therapy to Treat Wounds in Painful Skin Disorder
- ZEVASKYN, the first and only cell-based gene therapy for patients with recessive dystrophic epidermolysis bullosa (RDEB), now commercially available in the U.S. - - Ann …